AU2006306906B2 - S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same - Google Patents

S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same Download PDF

Info

Publication number
AU2006306906B2
AU2006306906B2 AU2006306906A AU2006306906A AU2006306906B2 AU 2006306906 B2 AU2006306906 B2 AU 2006306906B2 AU 2006306906 A AU2006306906 A AU 2006306906A AU 2006306906 A AU2006306906 A AU 2006306906A AU 2006306906 B2 AU2006306906 B2 AU 2006306906B2
Authority
AU
Australia
Prior art keywords
strontium
omeprazole
hydrate
crystalline
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006306906A
Other languages
English (en)
Other versions
AU2006306906A1 (en
Inventor
Tae Hee Ha
Eun Young Kim
Won Jeoung Kim
Young Hoon Kim
Gwan Sun Lee
Hee Sook Oh
Chang Hee Park
Kwee Hyun Suh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Science Co Ltd
Original Assignee
Hanmi Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Science Co Ltd filed Critical Hanmi Science Co Ltd
Publication of AU2006306906A1 publication Critical patent/AU2006306906A1/en
Application granted granted Critical
Publication of AU2006306906B2 publication Critical patent/AU2006306906B2/en
Assigned to HANMI HOLDINGS CO., LTD. reassignment HANMI HOLDINGS CO., LTD. Request for Assignment Assignors: HANMI PHARM. CO., LTD.
Assigned to HANMI SCIENCE CO., LTD. reassignment HANMI SCIENCE CO., LTD. Request to Amend Deed and Register Assignors: HANMI HOLDINGS CO., LTD.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2006306906A 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same Ceased AU2006306906B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR10-2005-0101059 2005-10-26
KR20050101059 2005-10-26
KR2006000760 2006-03-06
KRPCT/KR2006/000760 2006-03-06
PCT/KR2006/004369 WO2007049914A1 (en) 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Publications (2)

Publication Number Publication Date
AU2006306906A1 AU2006306906A1 (en) 2007-05-03
AU2006306906B2 true AU2006306906B2 (en) 2010-02-04

Family

ID=37967988

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006306906A Ceased AU2006306906B2 (en) 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Country Status (8)

Country Link
JP (1) JP5017274B2 (ru)
AU (1) AU2006306906B2 (ru)
CA (1) CA2626085C (ru)
IL (1) IL190709A (ru)
MY (1) MY140986A (ru)
NO (1) NO20082358L (ru)
RU (1) RU2372345C1 (ru)
WO (1) WO2007049914A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
CN116102538A (zh) * 2023-01-29 2023-05-12 山东省分析测试中心 一种转晶制备三水合艾司奥美拉唑镁的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
WO2004099182A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
SI1651217T1 (sl) * 2003-07-23 2008-08-31 Nycomed Gmbh Alkalne soli inhibitorjev protonske ÄŤrpalke
KR20080007508A (ko) * 2005-05-06 2008-01-21 그렌마크 파머수티칼스 엘티디. 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물

Also Published As

Publication number Publication date
JP2009513625A (ja) 2009-04-02
NO20082358L (no) 2008-07-25
CA2626085C (en) 2011-12-06
MY140986A (en) 2010-02-12
JP5017274B2 (ja) 2012-09-05
WO2007049914A1 (en) 2007-05-03
CA2626085A1 (en) 2007-05-03
IL190709A0 (en) 2008-11-03
RU2372345C1 (ru) 2009-11-10
IL190709A (en) 2012-03-29
AU2006306906A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
US8586752B1 (en) Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
PL131190B1 (en) Process for preparing novel derivatives of dihydropyridine
SK391091A3 (en) Crystalline paroxetine hydrochloride hemihydrate, pharmacuetical composition containing the same and its use
KR100878698B1 (ko) 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
AU2006306906B2 (en) S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
CA2366391C (en) Aspartate derivative of amlodipine
AU2008211906B2 (en) Atorvastatin strontium salt and pharmaceutical composition comprising same
EP3398946A1 (en) Salt of morpholine derivative and crystalline form thereof, as well as preparation method, pharmaceutical composition and use of the same
US9034904B2 (en) Forms of dexlansoprazole and processes for the preparation thereof
KR101307712B1 (ko) 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및 이를 포함하는 약학 조성물
CZ12613U1 (cs) Chemická sloučenina amlodipinaspartát a farmaceutický prostředek
KR20130063762A (ko) 신규 에스라베프라졸, 이의 알칼리금속 및 알칼리토금속염 및 이의 제조방법

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: HANMI HOLDINGS CO., LTD.

Free format text: FORMER OWNER WAS: HANMI PHARM. CO., LTD.

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PATENTEE TO READ HANMI SCIENCE CO., LTD. .

MK14 Patent ceased section 143(a) (annual fees not paid) or expired